首页> Journal of thrombosis and thrombolysis> Laboratory measurement of the non-vitamin K antagonist oral anticoagulants: selecting the optimal assay based on drug, assay availability, and clinical indication

Laboratory measurement of the non-vitamin K antagonist oral anticoagulants: selecting the optimal assay based on drug, assay availability, and clinical indication

导出原文传递

翻译打印收藏纠错

第一作者： Cuker, Adam

作者： Cuker, Adam ^[1]

作者单位： Univ Penn, Perelman Sch Med, Dept Med, 3400 Spruce St, Philadelphia, PA 19104 USA ^[1]

关键词 Apixaban Dabigatran Edoxaban Measurement Monitoring Rivaroxaban

发布时间 2017-04-05

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Journal of thrombosis and thrombolysis

2016年41卷2期

241-247页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览1

Journal of thrombosis and thrombolysis

2016年41卷2期

241-247页

检索历史清除

Laboratory measurement of the non-vitamin K antagonist oral anticoagulants: selecting the optimal assay based on drug, assay availability, and clinical indication

Journal of thrombosis and thrombolysis

相似文献

同项目论文

Journal of thrombosis and thrombolysis

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Laboratory measurement of the non-vitamin K antagonist oral anticoagulants: selecting the optimal assay based on drug, assay availability, and clinical indication

Journal of thrombosis and thrombolysis

相似文献

同项目论文

Journal of thrombosis and thrombolysis

相关期刊

检索历史清除